| Fluoxetine | rho = 0.25 | rho = 0.5 | rho = 0.75 | rho = 1.0 |
| 8‐16 weeks (66 treated vs 79 controls) Fixed effects model | ‐1.1 (95% CI ‐0.5 to ‐1.7) | ‐1.1 (95% CI ‐0.5 to ‐1.7) | ‐1.0 (95% CI ‐0.4 to ‐1.5) | ‐1.2 (95% CI ‐0.5 to ‐1.9) |
| Heterogeneity (q, p value) | q = 1.31, p = 0.73 | q = 1.57, p = 0.67 | q = 2.05, p = 0.56 | q = 0.63, p = 0.73 |
| Random effects model | ‐1.1 (95% CI ‐0.5 to ‐1.7) | ‐1.1 (95% CI ‐0.5 to ‐1.7) | ‐1.0 (95% CI ‐0.4 to ‐1.5) | ‐1.2 (95% CI ‐0.5 to ‐1.9) |
| Heterogeneity (q, p value) | q = 1.31, p = 0.73 | q = 1.57, p = 0.67 | q = 2.05, p = 0.56 | q = 0.63, p = 0.73 |
| 24‐26 weeks (45 treated vs 52 controls) Fixed effects model | ‐1.1 (95% CI ‐0.7 to ‐1.5) | ‐1.1 (95% CI ‐0.7 to ‐1.5) | ‐1.0 (95% CI ‐0.6 to ‐1.4) | ‐0.7 (95% CI ‐0.5 to ‐0.9) |
| Heterogeneity (q, p value) | q = 1.15, p = 0.77 | q = 1.26, p = 0.74 | q = 1.58, p = 0.66 | q = 5.99, p = 0.11 |
| Random effects model | ‐1.1 (95% CI ‐0.7 to ‐1.5) | ‐1.1 (95% CI ‐0.7 to ‐1.5) | ‐1.0 (95% CI ‐0.6 to ‐1.4) | ‐0.9 (95% CI ‐0.4 to ‐1.3) |
| Heterogeneity (q, p value) | q = 1.15, p = 0.77 | q = 1.26, p = 0.74 | q = 1.58, p = 0.66 | q = 5.99, p = 0.11 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.